The future of disease management. Interview by Ian Morrison
Nash, D.B.
Managed Care 16(9 Suppl. 9): 16-17
2007
ISSN/ISBN: 1062-3388 PMID: 17982776 Document Number: 611403
Document emailed within 1 workday
Related Documents
Flor, T.J. 2011: A sustainable future: the 2011 MDA president's interview Northwest Dentistry 90(2): 19-22 78Crowe, V. 1983: Ready to face the future. Interview by Laurence Dopson Nursing Times 79(29): Suppl. 8 11
Krzesinski, J.-M.; Scheen, A.J. 2015: Diabetic kidney disease: current management and potential future options Revue Medicale Suisse 11(483): 1534-1538; 1540-1542
Eleti, S. 2016: Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions Psychiatria Danubina 28(Suppl-1): 136-140
Le, L.Cu.; Vu, L.T.H. 2012: Audio computer-assisted self interview compared to traditional interview in an HIV-related behavioral survey in Vietnam Medicc Review 14(4): 26-31
Burger, D. 1995: The first interview as a basis for good relations with the patient. The decisive first interview Krankenpflege. Soins Infirmiers 88(10): 53-58
Murshed, R.; Douglas, R.M.; Ranmuthugala, G.; Caldwell, B. 2004: Clinicians' roles in management of arsenicosis in Bangladesh: interview study BMJ 328(7438): 493-494
Ammer, D.S. 1981: THPM interview: Dean Ammer, father of hospital materials management Topics in Hospital Pharmacy Management 1(2): 69-82
Bronfman, J. 2005: Interview with Jeffrey Bronfman, representative mestre for the União do Vegetal Church in the United States. Interview by Marlene Dobkin de Rios and Charles S Grob Journal of Psychoactive Drugs 37(2): 189-191
Li, Y.; Guldan, G.S.; Jia, F.; Zhai, F.; Shi, H.; Ye, X.; He, L. 2004: Feasibility of telephone screening interview in a validity and reliability study of telephone interview to assess dietary intake in Beijing, Shanghai and Hong Kong Wei Sheng Yan Jiu 33(4): 486-489
L'Espérance, G.; Lamoureux, C.; Giroux, Y. 1977: The Verner-Morrison syndrome L'Union Medicale du Canada 106(6): 847-852
Barnes, J.M. 1975: John Morrison Barnes Lancet 2(7938): 777
Merdzhanov, M.; Damianov, D.; Mendizova, A.; Damianov, B.; Bozhanov, V. 1979: Case of Verner-Morrison syndrome Khirurgiia 32(4): 352-356
Chichetti, S.; Bader, H.; Smith, S.; Barnett, N.; Barecki, R.; Testa, D.; Giannini, J.; Bass, D.; Vines, I.; DiSalvo, P. 2002: Using host response modifiers in the treatment of periodontal disease. "The clinicians' view". [Interview Practical Procedures and Aesthetic Dentistry: Ppad 14(9): Suppl. 12-5
Voss, J.; Herzog, K.H.; Zastrow, R.; Putzke, H.P. 1975: Surgical treatment of the Verner-morrison syndrome Zentralblatt für Chirurgie 100(9): 546-553
Hodgson, M.; Ormerod, C. 1985: Case mix management--management tool of the future? Canadian Nurse 81(10): 17-20
Grenier, J.F.; Marescaux, J.; Michel, F.; Sava, G.; Kachelhoffer, J. 1979: Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome La Nouvelle Presse Medicale 8(18): 1505-1508
Charleux, H. 1982: The Verner-Morrison syndrome: endocrine cholera or vipoma? La Nouvelle Presse Medicale 11(11): 859-862
Burkman, R.T. 1994: Noncontraceptive effects of hormonal contraceptives: Bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertility American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1569-1575
Várkonyi, T.T.; Velösy, B.; Nagy, I.; Németh, J.; Lonovics, J. 1993: Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin Orvosi Hetilap 134(47): 2599-2602